Prediction of the maximal tolerated dose (MTD) and therapeutic effect of anticancer drugs in humans: integration of pharmacokinetics with pharmacodynamics and toxicodynamics
- 31 March 1995
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 21 (2) , 133-157
- https://doi.org/10.1016/0305-7372(95)90024-1
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Prediction of the pharmacokinetics of cefodizime and cefotetan in humans from pharmacokinetic parameters in animals.Journal of Pharmacobio-Dynamics, 1990
- Clinical Pharmacokinetics-Pharmacodynamicsof Anticancer DrugsClinical Pharmacokinetics, 1989
- Multicompartment models of cancer chemotherapy incorporating resistant cell populationsJournal of Pharmacokinetics and Biopharmaceutics, 1987
- Prediction of the volumes of distribution of basic drugs in humans based on data from animalsJournal of Pharmacokinetics and Biopharmaceutics, 1984
- Physiological pharmacokinetics of ethoxybenzamide based on biochemical data obtainedin vitro as well as on physiological dataJournal of Pharmacokinetics and Biopharmaceutics, 1982
- In vitro andin vivo evaluation of the tissue-to-blood partition coefficient for physiological pharmacokinetic modelsJournal of Pharmacokinetics and Biopharmaceutics, 1982
- Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1982
- Animal scale-upJournal of Pharmacokinetics and Biopharmaceutics, 1973
- A pharmacodynamic model for cell-cycle-specific chemotherapeutic agentsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Mathematical representations of cancer chemotherapy effectsJournal of Pharmacokinetics and Biopharmaceutics, 1973